Frontier Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.6M | Sell |
|
|||||
2025
Q1 | $9.48M | Sell |
|
|||||
2024
Q4 | $12.7M | Sell |
|
|||||
2024
Q3 | $40.3M | Sell |
|
|||||
2024
Q2 | $29.8M | Buy |
|
|||||
2024
Q1 | $45.3M | Buy |
|
|||||
2023
Q4 | $43.1M | Buy |
|
|||||
2023
Q3 | $32M | Sell |
|
|||||
2023
Q2 | $49.8M | Sell |
|
|||||
2023
Q1 | $50.7M | Sell |
|
|||||
2022
Q4 | $42.7M | Buy |
|
|||||
2022
Q3 | $18.5M | Buy |
|
|||||
2022
Q2 | $20.8M | Sell |
|
|||||
2022
Q1 | $37.1M | Sell |
|
|||||
2021
Q4 | $46.5M | Sell |
|
|||||
2021
Q3 | $59.9M | Sell |
|
|||||
2021
Q2 | $93.5M | Sell |
|
|||||
2021
Q1 | $99.7M | Sell |
|
|||||
2020
Q4 | $153M | Sell |
|
|||||
2020
Q3 | $145M | Sell |
|
|||||
2020
Q2 | $143M | Buy |
|
|||||
2020
Q1 | $71.1M | Buy |
|
|||||
2019
Q4 | $95.5M | Buy |
|
|||||
2019
Q3 | $76.8M | Sell |
|
|||||
2019
Q2 | $103M | Sell |
|
|||||
2019
Q1 | $85.5M | Sell |
|
|||||
2018
Q4 | $77.9M | Sell |
|
|||||
2018
Q3 | $125M | Buy |
|
|||||
2018
Q2 | $68.9M | Buy |
|
|||||
2018
Q1 | $45.2M | Buy |
|
|||||
2017
Q4 | $46.9M | Sell |
|
|||||
2017
Q3 | $43.2M | Buy |
|
|||||
2017
Q2 | $12.3M | Buy |
|